.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Citi
Argus Health
Dow
US Army
Covington
Cantor Fitzgerald
Moodys
UBS

Generated: June 23, 2017

DrugPatentWatch Database Preview

Citalopram hydrobromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for citalopram hydrobromide and what is the scope of citalopram hydrobromide patent protection?

Citalopram hydrobromide
is the generic ingredient in two branded drugs marketed by Apotex Inc, Jubilant Generics, Aurobindo Pharma Ltd, Teva Pharms, Torrent Pharms, Forest Labs, Silarx, Aurobindo, Pliva, Sun Pharm Inds Inc, Actavis Elizabeth, Invagen Pharms, Watson Labs, Sandoz, Epic Pharma Llc, Mylan Pharms Inc, Dr Reddys Labs Ltd, Mylan, Natco Pharma Ltd, Roxane, West-ward Pharms Int, Cipla Ltd, Epic Pharma, Torpharm, G And W Labs Inc, Hetero Labs Ltd Iii, Sun Pharm Inds, Glenmark Generics, Biovail Labs Intl, Taro, and Amneal Pharms Ny, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-five drug master file entries for citalopram hydrobromide. Sixty-seven suppliers are listed for this compound.

Summary for Generic Name: citalopram hydrobromide

Tradenames:2
Patents:1
Applicants:31
NDAs:35
Drug Master File Entries: see list55
Suppliers / Packagers: see list67
Bulk Api Vendors: see list74
Clinical Trials: see list196
Patent Applications: see list1,790
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:citalopram hydrobromide at DailyMed

Pharmacology for Ingredient: citalopram hydrobromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077141-002Apr 10, 2008DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
CAPSULE;ORAL077668-002Feb 28, 2007DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
CAPSULE;ORAL077668-001Feb 28, 2007DISCNNoNo► Subscribe► Subscribe
Roxane
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077041-001Nov 23, 2004DISCNNoNo► Subscribe► Subscribe
Invagen Pharms
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077534-002Oct 3, 2006ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
US Department of Justice
Accenture
Moodys
Cerilliant
Cipla
Express Scripts
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot